Acquisition and loss of best walking skills in children and young people with bilateral cerebral palsy.


Journal

Developmental medicine and child neurology
ISSN: 1469-8749
Titre abrégé: Dev Med Child Neurol
Pays: England
ID NLM: 0006761

Informations de publication

Date de publication:
02 2022
Historique:
revised: 24 03 2021
received: 31 08 2020
accepted: 12 07 2021
pubmed: 20 8 2021
medline: 19 2 2022
entrez: 19 8 2021
Statut: ppublish

Résumé

To explore factors predicting acquisition and loss of best walking ability in young people with bilateral cerebral palsy (CP). In our population cohort (Study of Hips And Physical Experience) of 338 children (201 males, 137 females) with bilateral CP, age at achieving walking was recorded and walking ability predicted from early motor milestones. Walking was assessed at 5 to 8 years (mean 7y) and in 228 of 278 survivors at 13 to 19 years (mean 16y). Parent carers reported their view of any loss of best achieved walking. Factors potentially associated with loss of best achieved walking were explored: severity and type of motor disorder; intellect and communication; manipulative skill; general health and comorbidity; pain; orthopaedic surgery; musculoskeletal spine and lower limb deformity; weight; fatigue; mood; and presence of regular exercise regime. The ability to walk independently was reliably predicted by the motor milestone 'getting to sit and maintain sitting' by the age of 36 months (without aids) and 55 months (with aids). Forty-five per cent of the cohort never walked 10 steps independently. Not all who achieved walking without aids were still doing so by a mean age of 16 years, which was associated with later age at achieving walking and the degree of musculoskeletal deformity, as was the parent carers' report of loss of best walking. In this study, development of musculoskeletal deformity was a significant factor in not maintaining best achieved walking by mean age 16 years, which is most likely to occur in young people whose walking ability is with aids over short distances or in therapy only. Prediction of future walking ability in a child with bilateral CP can be made from early motor milestones.

Identifiants

pubmed: 34410016
doi: 10.1111/dmcn.15015
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

235-242

Informations de copyright

© 2021 Mac Keith Press.

Références

Bleck EE. Locomotor prognosis in cerebral palsy. Dev Med Child Neurol 1975; 17: 18-25.
Rosenbaum PL, Walter SD, Hanna SE, Palisano RJ, Russell DJ, Raina P, et al. Prognosis for gross motor function in cerebral palsy: creation of motor development curves. JAMA 2002; 288: 1357-63.
Wu YW, Day SM, Strauss DJ, Shavelle RM. Prognosis for ambulation in cerebral palsy: a population-based study. Pediatrics 2004; 114: 1264-71.
Beckung E, Hagberg G, Uldall P, Cans C. Probability of walking in children with cerebral palsy in Europe. Pediatrics 2008; 121: e187-92.
Begnoche DM, Chiarello LA, Palisano RJ, Gracely EJ, McCoy SW, Orlin MN. Predictors of independent walking in young children with cerebral palsy. Phys Ther 2016; 96: 183-92.
Tieman B, Palisano RJ, Gracely EJ, Rosenbaum PL. Variability in mobility of children with cerebral palsy. Pediatr Phys Ther 2007; 19: 180-7.
National Institute for Health and Care Excellence. Cerebral palsy in under 25s: assessment and management. Guideline NG62. National Institute for Health and Care Excellence, 2017. https://www.nice.org.uk>guidance>ng62.
Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol 1997; 39: 214-23.
Jahnsen R, Villien L, Egeland T, Stanghelle JK. Locomotion skills in adults with cerebral palsy. Clin Rehabil 2004; 18: 309-16.
Morgan P, McGinley J. Gait function and decline in adults with cerebral palsy: a systematic review. J Disabil Rehabil 2014; 36: 1-9.
Strauss D, Ojdana K, Shavelle R, Rosenbloom L. Decline in function and life expectancy of older persons with cerebral palsy. NeuroRehabilitation 2004; 19: 69-78.
Van der slot WMA, Nieuwenhuijsen C, Van den berg-emons RJG, Bergen MP, Hilberink SR, Stam HJ, Roebroeck ME. Chronic pain, fatigue, and depressive symptoms in adults with spastic bilateral cerebral palsy. Dev Med Child Neurol 2012; 54: 836-42.
Morgan P. Towards a better understanding of fatigue experienced by adults with cerebral palsy. Dev Med Child Neurol 2017; 59: 344-5.
McPhee PG, Brunton LK, Timmons BW, Bentley T, Gorter JW. Fatigue and its relationship with physical activity, age, and body composition in adults with cerebral palsy. Dev Med Child Neurol 2017; 59: 367-73.
Chin H-c, Ada L, Chen C. Changes in walking performance between childhood and adulthood in cerebral palsy: a systematic review. Dev Neurorehabil 2020; 23: 343-8.
Johnson DC, Damiano DL, Abel MF. The evolution of gait in childhood and adolescent cerebral palsy. J Pediatr Orthopaed 1997; 17: 392-6.
Bell KJ, Õunpuu S, DeLuca PA, Romness MJ. Natural progression of gait in children with cerebral palsy. J Pediatr Orthopaed 2002; 22: 677-82.
Gough M, Eve LC, Robinson RO, Shortland AP. Short-term outcome of multilevel surgical intervention in spastic diplegic cerebral palsy compared with the natural history. Dev Med Child Neurol 2004; 46: 91-7.
Day SM, Strauss DJ, Vachon PJ, Rosenbloom L, Shavelle RM, Wu YW. Growth patterns in a population of children and adolescents with cerebral palsy. Dev Med Child Neurol 2007; 49: 167-71.
Bottos M, Gericke C. Ambulatory capacity in cerebral palsy: prognostic criteria and consequences for intervention. Dev Med Child Neurol 2003; 45: 786-790.
Shortland A, Harris C, Gough M, Robinson RO. Architecture of the medial gastrocnemius in children with spastic diplegia. Dev Med Child Neurol 2002; 44: 158-63.
Shortland A. Muscle deficits in cerebral palsy and early loss of mobility: can we learn anything from our elders? Dev Med Child Neurol 2009; 54: 59-63.
Noble JJ, Fry NR, Lewis AP, Keevil SF, Gough M, Shortland AP. Lower limb muscle volumes in bilateral spastic cerebral palsy. Brain Dev 2014; 36: 294-300.
Eken M, Braendvik S, Bardal EM, Houdijk H, Dallmeijer A, Roeleveld K. Lower limb muscle fatigue during walking in children with cerebral palsy. Dev Med Child Neurol 2019; 61: 212-8.
Dan B. Progressive course in cerebral palsy? Dev Med Child Neurol 2007; 49: 644.
Scrutton D, Baird G, Smeeton N. Hip dysplasia in bilateral cerebral palsy: incidence and natural history in children aged 18 months to 5 years. Dev Med Child Neurol 2001; 43: 586-600.
Baird G, Allen E, Scrutton D, Knight A, McNee A, Will E, Elbourne D. Mortality from 1 to 16-18 years in bilateral cerebral palsy. Arch Dis Child 2011; 96: 1077-81.
Harvey AR, Morris ME, Graham HK, Wolfe R, Baker R. Reliability of the functional mobility scale for children with cerebral palsy. Phys Occup Ther Pediatr 2010; 30: 139-49.
Fairhurst C, Shortland A, Chandler S, Will E, Scrutton D, Simonoff E, Baird G. Factors associated with pain in adolescents with bilateral cerebral palsy. Dev Med Child Neurol 2019; 61: 929-36.
Dunn LM, Dunn DM. The British Picture Vocabulary Scale. GL Assessment Limited, 2009. https://www.gl-assessment.co.uk.
Ravens-Sieberer U, Gosch A, Rajmil L, Erhart M, Bruil J, Duer W, et al. KIDSCREEN-52 quality-of-life measure for children and adolescents. Exp Rev Pharmacoeconom Outcome Res 2005; 5: 353-64.
National Institute for Health and Care Excellence. Cerebral palsy in adults. Guideline NG119. National Institute for Health and Care Excellence, 2019. https://nice.org.uk>guidance>ng119.

Auteurs

Gillian Baird (G)

Newcomen Neurodevelopmental Service, Paediatric Neurosciences, Guy's & St Thomas' NHS Trust, King's Health Partners, Evelina London Children's Hospital, London, UK.

Susie Chandler (S)

Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Adam Shortland (A)

Biomedical Engineering & Imaging Science, Faculty of Life Sciences and Medicine, King's College London, London, UK.

Elspeth Will (E)

Newcomen Neurodevelopmental Service, Paediatric Neurosciences, Guy's & St Thomas' NHS Trust, King's Health Partners, Evelina London Children's Hospital, London, UK.

Emily Simonoff (E)

Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

David Scrutton (D)

Newcomen Neurodevelopmental Service, Paediatric Neurosciences, Guy's & St Thomas' NHS Trust, King's Health Partners, Evelina London Children's Hospital, London, UK.

Charlie Fairhurst (C)

Newcomen Neurodevelopmental Service, Paediatric Neurosciences, Guy's & St Thomas' NHS Trust, King's Health Partners, Evelina London Children's Hospital, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH